Olaplex (OLPX) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales were $119.1 million, down 3.6% year-over-year, with sequential improvement from Q2 and international underperformance.

• Adjusted EBITDA was $44.6 million with a margin of 37.5%, down from 41.7% in Q3 2023.

• Net income for Q3 was $14.8 million, with adjusted net income at $28.7 million; diluted EPS was $0.02, adjusted diluted EPS $0.04.

• The company is focused on brand growth, innovation, distributor realignment, and international expansion amid a challenging environment.

• Three new products were launched, including No. 5 Leave-In Conditioner, Bond Shaper Curl Rebuilding Treatment, and No. 10 Bond Shaper Curl Defining Gel.

Financial highlights

• Q3 net sales: $119.1 million, down 3.6% year-over-year; U.S. sales down 3.3%, international down 3.9%.

• Direct-to-consumer sales grew 6.8% to $34.3 million; specialty retail fell 1.3% to $42.6 million; professional channel declined 12.6% to $42.2 million.

• Adjusted gross margin improved to 70.8% from 69.7% a year ago; gross profit margin was 68.6% from 67.6%.

• Adjusted EBITDA declined 13.4% to $44.6 million; adjusted net income was $28.7 million.

• Cash and equivalents at Q3 end: $538.8 million; long-term debt: $645 million.

Outlook and guidance

• FY2024 net sales guidance lowered to $405–$415 million from $435–$463 million.

• Adjusted EBITDA expected at $121–$127 million (margin 29.9%–30.6%), down from prior $143–$159 million.

• Adjusted net income guidance reduced to $67–$73 million (prior: $87–$100 million).

• Adjusted gross margin forecasted at 70.9%–71.6%, below initial expectations.

• Increased promotional activity and slower international demand recovery expected in Q4.